Methylnaltrexone Bromide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06800 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | congenital hypotrichosis milia | KG + DL |
| 2 | hypotrichosis simplex of the scalp | KG + DL |
| 3 | exercise-induced malignant hyperthermia | KG + DL |
| 4 | common cold | KG + DL |
| 5 | alopecia | KG + DL |
| 6 | diffuse alopecia areata | KG + DL |
| 7 | respiratory failure | KG + DL |
| 8 | familial periodic paralysis | KG + DL |
| 9 | obsolete hyperuricemia (disease) | KG + DL |
| 10 | trigeminal autonomic cephalalgia | KG + DL |
| 11 | adrenal gland pheochromocytoma | KG + DL |
| 12 | benign neoplasm of adrenal medulla | KG + DL |
| 13 | primary hereditary glaucoma | KG + DL |
| 14 | headache disorder | KG + DL |
| 15 | open-angle glaucoma | KG + DL |
| 16 | hypokalemic periodic paralysis | KG + DL |
| 17 | duodenum cancer | KG + DL |
| 18 | adrenal medulla cancer | KG + DL |
| 19 | sympathetic nervous system disease | KG + DL |
| 20 | hypouricemia, renal | KG + DL |
| 21 | King-Denborough syndrome | KG + DL |
| 22 | malignant tumor of extrahepatic bile duct | KG + DL |
| 23 | duodenal disease | KG + DL |
| 24 | duodenal villous adenoma | KG + DL |
| 25 | periampullary adenoma | KG + DL |
| 26 | ocular tuberculosis | KG + DL |
| 27 | malignant hyperthermia, susceptibility to | KG + DL |
| 28 | small intestine cancer | KG + DL |
| 29 | ampulla of vater neoplasm | KG + DL |
| 30 | heart cancer | KG + DL |
| 31 | duodenal neuroendocrine neoplasm | KG + DL |
| 32 | thyrotoxic periodic paralysis, susceptibility to | KG + DL |
| 33 | carcinoma of the ampulla of vater | KG + DL |
| 34 | small intestine adenocarcinoma | KG + DL |
| 35 | hypoxanthine guanine phosphoribosyltransferase partial deficiency | KG + DL |
| 36 | epicardium cancer | KG + DL |
| 37 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 38 | primitive portal vein thrombosis | KG + DL |
| 39 | hepatoportal sclerosis | KG + DL |
| 40 | idiopathic copper-associated cirrhosis | KG + DL |
| 41 | hepatopulmonary syndrome | KG + DL |
| 42 | guttate psoriasis | KG + DL |
| 43 | benign neoplasm of small intestine | KG + DL |
| 44 | duodenal adenocarcinoma | KG + DL |
| 45 | ileal neoplasm | KG + DL |
| 46 | malignant hyperthermia of anesthesia | KG + DL |
| 47 | thyrotoxic periodic paralysis | KG + DL |
| 48 | sunburn | KG + DL |
| 49 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 50 | corneal pigmentation | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.